Quick Listen: Scrip’s Five Must-Know Things
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
This episode includes insights from around the biopharma world for the business week ended 15 January 2021.
This week, we take a look some of the major news to come out of the J.P. Morgan Healthcare Conference, a big oncology deal for one Chinese company, lessons in Alzheimer's development, and a pipeline update from one large German firm.
These and all our other podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Play, SoundCloud and TuneIn - and also now on Spotify Podcasts - and also via smart speakers if one of these channels has been set up as your default podcast provider.
Stories mentioned in this episode:
(Also see "J.P. Morgan Day 1: Companies Make Deal-Making, COVID-19 Promises" - Scrip, 11 Jan, 2021.)
(Also see "J.P. Morgan Day 2: Pharma Offers (Some) Views On Drug Pricing Reform" - Scrip, 12 Jan, 2021.)
(Also see "BeiGene Ties Up With Novartis To Take PD-1 Global In $2.2bn+ Deal" - Scrip, 12 Jan, 2021.)
(Also see "An Alzheimer’s Win: How Lilly Designed Donanemab Trial To Succeed" - Scrip, 12 Jan, 2021.)
(Also see "Bayer Puts Spotlight On Pharma Pipeline" - Scrip, 13 Jan, 2021.)